Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ellsworth

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|December 1, 1992
Statement: occupational therapy services in work practiceK Jacobs, C Bettencourt, P Ellsworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitorsAnthony K Ogawa, Chris A Willoughby, Raynald Bergeron, et al.
Hospitals & Health Networks|July 20, 1996
Talk shows ... the CEOs of seven large health systems take you on a verbal journeyB Powell, R Norling, G Warden, et al.
Journal of Molecular Graphics & Modelling|March 23, 2005
Modeling aided design of potent glycogen phosphorylase inhibitorsQiaolin Deng, Zhijian Lu, Joann Bohn, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase aKeith G Rosauer, Anthony K Ogawa, Chris A Willoughby, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
A new class of glycogen phosphorylase inhibitorsZhijian Lu, Joann Bohn, Raynald Bergeron, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2016
Inhibition of Factor XIa Reduces the Frequency of Cerebral Microembolic Signals Derived from Carotid Arterial Thrombosis in RabbitsXinkang Wang, Stan Kurowski, Weizhen Wu, et al.
Teratology|February 1, 1997
Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)S Prahalada, A F Tarantal, G S Harris, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2011
Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetesMargaret Wu, Sheo B Singh, Jun Wang, et al.
Journal of Medicinal Chemistry|February 13, 2016
Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor ProgramTing Zhang, Yong Liu, Xianshu Yang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|December 1, 1992
Statement: occupational therapy services in work practiceK Jacobs, C Bettencourt, P Ellsworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitorsAnthony K Ogawa, Chris A Willoughby, Raynald Bergeron, et al.
Hospitals & Health Networks|July 20, 1996
Talk shows ... the CEOs of seven large health systems take you on a verbal journeyB Powell, R Norling, G Warden, et al.
Journal of Molecular Graphics & Modelling|March 23, 2005
Modeling aided design of potent glycogen phosphorylase inhibitorsQiaolin Deng, Zhijian Lu, Joann Bohn, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase aKeith G Rosauer, Anthony K Ogawa, Chris A Willoughby, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
A new class of glycogen phosphorylase inhibitorsZhijian Lu, Joann Bohn, Raynald Bergeron, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2016
Inhibition of Factor XIa Reduces the Frequency of Cerebral Microembolic Signals Derived from Carotid Arterial Thrombosis in RabbitsXinkang Wang, Stan Kurowski, Weizhen Wu, et al.
Teratology|February 1, 1997
Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)S Prahalada, A F Tarantal, G S Harris, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2011
Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetesMargaret Wu, Sheo B Singh, Jun Wang, et al.
Journal of Medicinal Chemistry|February 13, 2016
Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor ProgramTing Zhang, Yong Liu, Xianshu Yang, et al.
Pageof 3